The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals

Blood

Volumn 94, Issue 3, 1999, Pages 1003-1011

  Marshall, Jason D ^b   Chehimi, Jihed ^b   Gri, Giorgia ^b   Kostman, Jay R ^b   Montaner, Luis J ^b   Trinchieri, Giorgio ^a  

^a WISTAR INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 12;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033179165     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.1003.415a15_1003_1011     Document Type: Article

References (43)

1. Trinchieri G: Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 16:365, 1998
2. Trinchieri G: Immunobiology of interleukin-12. Immunol Res 17:269, 1998
3. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387, 1992
4. Heinzel FP, Hujer AM, Ahmed FN, Rerko RM: In vivo production and function of IL-12 p40 homodimers. J Immunol 158:4381, 1997
5. Yoshimoto T, Wang CR, Yoneto T, Waki S, Sunaga S, Komagata Y, Mitsuyama M, Miyazaki J, Nariuchi H: Reduced T helper 1 responses in IL-12 p40 transgenic mice. J Immunol 160:588, 1998
6. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G: Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 160:5936, 1998
7. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 179:1361, 1994
8. Chehimi J, Ma X, Chouaib S, Zyad A, Nagashunmugam T, Wojcik L, Chehimi S, Nissim L, Frank I: Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res Hum Retroviruses 12:1141, 1996
9. Marshall JD, Robertson SE, Trinchieri G, Chehimi J: Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients. J Immunol 159:5705, 1997
10. Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G: Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 23:1826, 1993
11. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721, 1993
12. Romani L, Cenci E, Menacci A, Bistoni F, Puccetti P: T helper cell dichotomy to Candida albicans: Implications for pathology, therapy, and vaccine design. Immunol Res 14:148, 1995
13. Gazzinelli RT, Bala S, Stevens R, Baseler M, Wahl L, Kovacs J, Sher A: HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J Immunol 155:1565, 1995
14. Clerici M, Balotta C, Meroni L, Ferrario E, Riva C, Trabattoni D, Ridolfo A, Villa M, Shearer GM, Moroni M, Galli M: Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses 12:1053, 1996
15. + T cells from patients with AIDS. Eur J Immunol 17:1685, 1987
16. Wu CY, Warner RR, Carvajal DM, Chua AO, Minetti LJ, Chizzonite R, Mongini PKA, Stern AS, Gubler U, Presky DH, Gately MK: Biological function and distribution of human interleukin-12 receptor β chain. Eur J Immunol 26:345, 1996
17. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185:825, 1997
18. Leandersson AC, Bratt G, Hinkula J, Gilljam G, Cochaux P, Samson M, Sandstrom E, Wahren B: Induction of specific T-cell responses in HIV infection. AIDS 12:157, 1998
19. + lymphocyte responses to antiretroviral therapy of HIV infection. J AIDS Hum Retrovirol 13:320, 1996
20. Bailer RT, Holloway A, Anthony R, Lassiter S, Kostman J, Montaner LJ: Deficiency of IL-13 and IFN-γ secretion in HIV-infected individuals contributes to overall immune dysfunction. 5th Conference on Retroviruses and Opportunistic Infections 193:602, 1998 (abstr)
21. Chougnet C, Wynn TA, Clerici M, Landay AL, Kessler HA, Rusnak J, Melcher GP, Sher A, Shearer GM: Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 174:46, 1996
22. 2 production. Blood 89:570, 1997
23. Harrison TS, Levitz SM: Priming with IFN-γ restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. J Immunol 158:459, 1997
24. Harrison TS, Levitz SM: Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol 156:4492, 1996
25. Trinchieri G: Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr Opin Immunol 9:17-23, 1997
26. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U: A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc Natl Acad Sci USA 93:14002, 1996
27. Wu C, Warrier RR, Wang X, Presky DH, Gately MK: Regulation of interleukin-12 receptor β1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur J Immunol 27:147, 1997
28. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J Clin Invest 91:759, 1993
29. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, Trinchieri G: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 175:789, 1992
30. Fan J, Bass HZ, Fahey JL: Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J Immunol 151: 5031, 1993
31. Meyaard L, Hovenkamp E, Keet IP, Hooibrink B, de Jong IH, Otto SA, Miedema F: Single cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals: Decreased IFN-γ in the presence of preserved IL-4 production. J Immunol 157:2712, 1996
32. Pericle F, Pinto LA, Hicks S, Kirken RA, Sconocchia G, Rusnak J, Dolan MJ, Shearer GM, Segal DM: Cutting Edge: HIV-1 infection induces a selective reduction in STATS protein expression. J Immunol 160:28, 1998
33. Gollob JA, Murphy EA, Mahajan S, Schnipper CP, Ritz J, Frank DA: Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1. Blood 91:1341, 1998
34. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432, 1998
35. Jong R, Altare F, Haagen IA, Elferink DG, de Boer T, van Breda Vriesman PJC, Kabel PJ, Draaisma JMT, van Dissel JT, Kroon FP, Casanova JL, Ottenhoff THM: Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science 280: 1435, 1998
36. D'Andrea A, Aste-Amézaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041, 1993
37. Schumann RR, Rietschel ET, Loppnow H: The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol 183:279, 1994
38. Kusunoki T, Hailman E, Juan TS, Lichenstein HS, Wright SD: Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med 182:1673, 1995
39. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G: The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J Exp Med 183:147, 1996
40. Nockher WA, Bergmann L, Scherberich JE: Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol 98:369, 1994
41. Kitchens RL, Munford RS: CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol 160:1920, 1998
42. Herrera-Velit P, Reiner NE: Bacterial lipopolysaccharide induces the association and coordinate activation of p53/561yn and phosphatidylinositol 3-kinase in human monocytes. J Immunol 156:1157, 1996
43. Gri G, Savio D, Trinchieri G, Ma X: Synergistic regulation of the human interleukin-12 p40 promoter by NFKB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages. J Biol Chem 273:6431 1998